Advanced search
Publication Cover
Acta Oncologica Volume 33, 1994 - Issue 2
Journal homepage
164
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Primary or Metastatic Pleural Effusion with Intracavitary Cytosine Arabinoside and Cisplatin: A phase II study

Enrico Aitini Department of Medical Oncology, Ospedale Carlo Poma, Mantova
,
Giovanna Cavazzini Department of Medical Oncology, Ospedale Carlo Poma, Mantova
,
Enzo Pasquini Department of Medical Oncology, Ospedale degli Infermi, Rimini
,
Carla Rabbi Department of Medical Oncology, Ospedale Carlo Poma, Mantova
,
Fausto Colombo Department of Pneumology, Ospedale Cuasso al Monte, Varese, Italy
,
Maurizio Cantore Department of Medical Oncology, Ospedale Carlo Poma, Mantova
,
Pier Paolo Fattori Department of Medical Oncology, Ospedale degli Infermi, Rimini
,
Franca Pari Department of Medical Oncology, Ospedale Carlo Poma, Mantova
,
Alberto Bertuzzi Internal Medicine Departments, Ospedale Carlo Poma, Mantova
&
Franco Smerieri Department of Medical Oncology, Ospedale Carlo Poma, Mantova
 show all
Pages 191-194 | Received 27 May 1993, Accepted 08 Dec 1993, Published online: 08 Jul 2009

References

  • Bergerat J P, Drewinko B, Corry P. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D arabino-furanosylcytosine. Cancer Res 1981; 41: 25–30
  • Schilsky R L, Muscato J J, Muscato M S. Phase I clinical evaluation of cytarabine and cisplatin in patients with advanced cancer. Cancer Treat Rep 1984; 68: 1097–102
  • Markman M, Cleary S, King M E. Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusions. Med Pediatr Oncol 1985; 13: 191–3
  • Markman M, Howell S B. The intracavitary administration of cytarabine to patients with non-hematopoietic malignancies: an update. Semin Oncol 1987; 14(Suppl. 1)116–20
  • Markman H, Howell S B, Green M R. Combination intracavitary chemotherapy for malignant pleural disease. Cancer Drug Delivery 1984; 1: 333–6
  • Markman M. The intracavitary administration of cytarabine to patients with non-hematopoietic malignancies: Pharmaco-logic rationale and results of clinical trials. Semin Oncol 1985; 12(Suppl. 3)177–83
  • Pfeifle C E, Howell S B, Markman M. Intracavitary cisplatin chemotherapy for mesothelioma. Cancer Treat Rep 1985; 69: 205–7
  • Rusch V W, Figlin R, Godwin D. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions—A lung cancer study group trial. J Clin Oncol 1991; 9: 313–9
  • Frei E, III. Effect of dose and schedule on response. Cancer medicine, J F Holland, E Frei, III. Lea & Febiger, Philadelphia 1973; 717–30
  • Bogliolo V G, Lerza R, Bottino G B. Regional pharma-cokinetic selectivity of intrapleural cisplatin. Eur J Cancer 1991; 27: 839
  • Aitini E, Pasquini E, Cavazzini G. Local treatment of malignant pleural mesothelioma with intracavitary cytosine-arabinoside and cisplatin. Ann Oncol 1992; 3: 771–2
  • Anderson C B, Gordon W P, Ferguson T B. The treatment of malignant pleural effusions. Cancer 1974; 33: 916
  • Tattersal M NH. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusion. A randomized study. Med J Aust 1980; 2: 447–51
  • Ostrowsky M. An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavitary bleomycin. Cancer 1986; 57: 721–4
  • Reichman B, Markman M, Hakes T. Intraperitoneal cisplatin and etoposide in the treatment of refractory/ recurrent ovarian carcinoma. J Clin Oncol 1989; 7: 1327–32
  • Falkson G, Alberts A S, Falkson H C. Malignant pleural mesothelioma treatment: the current status of the art. Cancer Treat Rev 1988; 15: 231–42

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.